Events7th International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session S3. General of the event 7th International Electronic Conference on Medicinal Chemistry
Published date
02 Nov, 2021
Academic Editor
author-avatarJean Jacques Vanden Eynde
Citation
Abdelkader Tabbiche, Abdelaziz Bouchama, Synthesis, characterization, X-ray crystallography, acetyl cholinesterase inhibition and antioxidant activities of some novel hydrazones, in Proceedings of 7th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2021, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2021-11380
Share
Email
Facebook
Twitter
LinkedIn

Synthesis, characterization, X-ray crystallography, acetyl cholinesterase inhibition and antioxidant activities of some novel hydrazones

image
Abdelaziz Bouchama 2
1. Ferhat Abbas Setif 1 University, chemistry Department, Setif-ALGERIA Laboratoire de Chimie, Ingénierie Moleculaire et Nanostructures
2. Ferhat Abbas Setif 1 University, chemistry Department, Setif-ALGERIA
Abstract

Alzheimer's disease is the most common form of dementia in persons over the age of 65, and its etiology is linked to oxidative stress. In this work, an easy and efficient access to two new hydrazones Schiff bases as (2-Cl MHB and 2-Cl BHB). These compounds were prepared by condensation of 2-Chloro phenyl hydrazine with benzil.The structure of each of the two compounds was determined by the X-ray diffraction technique performed on single crystals. In a second part, an attempt to evaluate the biological properties is carried out on the two hydrazones such as the antioxidant power (by two methods: DPPH and CUPRAC) and the anti-cholinesterase activity (AChE, BChE) against the disease of Alzheimer's. The results obtained must be taken into account with other studies to improve their inhibitory activity.

Keywords
Hydrazone
DPPH
CUPRAC
AChE
BChE.
Poster
poster of 7 th conférence pdf.pdf
SHAP-based tools for ADMET compounds profiling on the example of metabolic stability optimization
Synthesis, butyrylcholinesterase inhibitory activity and molecular docking of novel hydroxylated 2-benzylbenzofuran derivatives